Ken Griffin Pro Mis Neurosciences Inc. Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 170,079 shares of PMN stock, worth $66,330. This represents 0.0% of its overall portfolio holdings.
Number of Shares
170,079
Previous 63,429
168.14%
Holding current value
$66,330
Previous $30,000
136.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PMN
# of Institutions
25Shares Held
10MCall Options Held
0Put Options Held
0-
Ally Bridge Group (Ny) LLC New York, NY6.23MShares$2.43 Million2.7% of portfolio
-
Armistice Capital, LLC New York, NY2.97MShares$1.16 Million0.02% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3295KShares$115,1220.03% of portfolio
-
Hrt Financial LP New York, NY68.1KShares$26,5420.0% of portfolio
-
Xtx Topco LTD London, X067.7KShares$26,3970.0% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...